H
High Tide Inc (HITI)
Official siteHEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ
$2.37
-0.10 (-4.05%)
Market Cap: $220.18M
Last updated: Nov 17, 2026 at 11:05 AM ET
High Tide Inc (HITI) Valuation Multiples
High Tide (HITI) trades at 0.4x sales and 3.0x book value. Its P/S of 0.4x is in line with its 5-year median.
Current Multiples
HITI reports in CAD, so earnings multiples appear here only when its per-share earnings can be confirmed. Its free cash flow yield is 5.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 0.4x |
| Price to book | 3.0x |
| EV/EBITDA | 69.7x |
| Price to FCF | 19.5x |
| EV/FCF | 22.2x |
| PEG | N/A |
| FCF yield | 5.1% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.4x | 0.4x | N/A |
| P/B | 3.0x | 1.8x | N/A |
Valuation History
Over the 4 of the 7 year ends shown that have a P/S, its P/S ranged from 0.3x in 2023 to 0.6x in 2024.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $2.65 | 0.5x | 3.7x |
| 2024 | $3.09 | 0.6x | 2.4x |
| 2023 | $1.63 | 0.3x | 1.3x |
| 2022 | $1.54 | 0.4x | 1.0x |
| 2021 | $4.25 | N/A | 2.1x |
| 2020 | $3.00 | N/A | N/A |
| 2019 | $2.04 | N/A | N/A |
P/E history is shown only for companies that report in US dollars.
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HITI
Is HITI stock overvalued?
GNG's valuation label for HITI is Fairly valued.
What is HITI's price to sales ratio?
High Tide has a price to sales ratio of 0.4x.
HITI pages: Overview, Financials, Valuation, Competitors